FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA and FTC Issue 13 Warning Letters to E liquid Companies for Misleadingly Marketing to Youth; FDA Investigates Underage Use of JUUL Devices The Continuum of Risk FDA issued 30 warning letters to telehealth companies for false and misleading claims about compounded GLP 1 products. This marks the second round of enforcement action since the agency's September crackdown on misleading In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness Don't Ignore an FDA Warning Letter: The Legal Risks Your Business Can't Afford